Is TRPC6 inhibition for FSGS a trick or a treat? — NephJC
This week, we will discuss a phase 2 trial of the TRPC6 inhibitor BI 764198 in FSGS—an early signal for a podocyte-targeted therapy showing proteinuria reduction but set against small numbers,...
nephjc.com